Anti-GDF7/ BMP12 functional antibody

Anti-GDF7/ BMP12 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to GDF7/GDF7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0942-Ab-1/ GM-Tg-hg-SE0942-Ab-2Anti-Human GDF7 monoclonal antibodyHuman
GM-Tg-rg-SE0942-Ab-1/ GM-Tg-rg-SE0942-Ab-2Anti-Rat GDF7 monoclonal antibodyRat
GM-Tg-mg-SE0942-Ab-1/ GM-Tg-mg-SE0942-Ab-2Anti-Mouse GDF7 monoclonal antibodyMouse
GM-Tg-cynog-SE0942-Ab-1/ GM-Tg-cynog-SE0942-Ab-2Anti-Cynomolgus/ Rhesus macaque GDF7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0942-Ab-1/ GM-Tg-felg-SE0942-Ab-2Anti-Feline GDF7 monoclonal antibodyFeline
GM-Tg-cang-SE0942-Ab-1/ GM-Tg-cang-SE0942-Ab-2Anti-Canine GDF7 monoclonal antibodyCanine
GM-Tg-bovg-SE0942-Ab-1/ GM-Tg-bovg-SE0942-Ab-2Anti-Bovine GDF7 monoclonal antibodyBovine
GM-Tg-equg-SE0942-Ab-1/ GM-Tg-equg-SE0942-Ab-2Anti-Equine GDF7 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0942-Ab-1/ GM-Tg-hg-SE0942-Ab-2; GM-Tg-rg-SE0942-Ab-1/ GM-Tg-rg-SE0942-Ab-2;
GM-Tg-mg-SE0942-Ab-1/ GM-Tg-mg-SE0942-Ab-2; GM-Tg-cynog-SE0942-Ab-1/ GM-Tg-cynog-SE0942-Ab-2;
GM-Tg-felg-SE0942-Ab-1/ GM-Tg-felg-SE0942-Ab-2; GM-Tg-cang-SE0942-Ab-1/ GM-Tg-cang-SE0942-Ab-2;
GM-Tg-bovg-SE0942-Ab-1/ GM-Tg-bovg-SE0942-Ab-2; GM-Tg-equg-SE0942-Ab-1/ GM-Tg-equg-SE0942-Ab-2
Products NameAnti-GDF7 monoclonal antibody
Formatmab
Target NameGDF7
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GDF7 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0942-Ag-1Recombinant multi-species GDF7/ BMP12 protein
    CytokineGM-Tg-g-SE0942-Ag-1growth differentiation factor 7 (GDF7) protein


    Target information

    Target IDGM-SE0942
    Target NameGDF7
    Gene ID151449,238057,252833,702462,102152821,111559870,286859,100147101
    Gene Symbol and SynonymsBMP12,GDF7
    Uniprot AccessionQ7Z4P5
    Uniprot Entry NameGDF7_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000143869
    Target ClassificationN/A

    The target: GDF7, gene name: GDF7, also named as BMP12. This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein may play a role in the differentiation of tendon cells and spinal cord interneurons. A mutation in this gene may be associated with increased risk for Barrett's esophagus and esophageal adenocarcinoma. [provided by RefSeq, Sep 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.